HR Execs on the Move

The Wound Pros

www.thewoundpros.com

 
The Wound Pros, LLC is a physician-owned Medicare Part B supplier of the industry’s most advanced wound care dressings. As a bonus, Wound Pros offers excellent clinical expertise which gives our patients the best opportunity to heal efficiently. Our vision is to change the way the world treats and manages non-healing wounds. Chronic non-healing wounds can compromise the quality of life for those living in long-term care facilities. The longer a wound remains open or unhealed, the greater the chance of unwanted complications such as infection, hospitalisation, and even amputation. At The Wound Pros, we are dedicated to meeting this ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.thewoundpros.com
  • 4640 Admiralty Way Suite 500
    Marina del Ray, CA USA 90292
  • Phone: 888.880.3451

Executives

Name Title Contact Details
Kenya Manning
Chief Human Resources Officer Profile
Michael MacDonald
Vice President of Sales and Marketing Profile

Similar Companies

Natura Bisse International

Natura Bisse International is a Irving, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

Fulcrum Health

Leveraging physical medicine to transform health care.

Pelton and Crane

Innovation and quality are traditions that have kept Pelton & Crane at the forefront of the dental industry for over 108 years. Pelton & Crane was founded by Dr. R.M. Pelton, a dentist who felt the need in his own practice for a furnace used to bake